Tag: Mylan

BCBS Report

Study: Children at Risk for Anaphylaxis Doubled From 2010 to 2016

The incidence of anaphylactic episodes is soaring according to an analysis by Blue Cross Blue Shield.

Canada EpiPen Shortage Expected to Last the Winter

Health Canada warns EpiPen shortage affecting the country will likely not be resolved until March.
Kaleo Booth

Auvi-Q Takes Center Stage at School Nurse Conference

One example of the changing market dynamics for epinephrine auto-injectors in light of recent developments.
Symjepi™ Prefilled Syringe

Welcome Symjepi™: Adamis’ Prefilled Epinephrine Syringe Receives FDA Approval

The additional competition should help lower costs across the emergency epinephrine market.
Mylan Chairman Robert Coury and CEO Heather Bresch

Mylan’s Chairman Was Paid $97.6 Million

Despite 2016 being a year when everything seemed to implode for the marketer of EpiPen.

Sanofi Files Suit Against Mylan for Anti-Competitive EpiPen Strategy

More legal troubles for the embattled marketer of EpiPen.

Kmart Announces Lower Price of Adrenaclick Generic

May cost as low as $0 to consumers with commercial health insurance.

A Deeper Look Into the Racketeering Lawsuit Against Mylan

The suit exposes a convoluted system that works to our detriment.

Mylan Issues EpiPen Recall for the United States

Please note this important recall and follow the instructions if you are affected.
Epipen 2 Pack

EpiPen Recalled in Australia

The recall is currently for Australia only.

Connect with Us